T HE TERM, "low output syndrome," has been applied to those occasions following open-heart surgery when cardiac output is inadequate to meet metabolic demands. It is implied that all the obvious extracardiac factors that might contribute to low output have been controlled, such as acid-base balance and ventilation, and thus the low output has -been assumed to be due to an inherent depression of myocardial contractility.
Although the etiology is usually unknown, it is probably in some manner related to events occurring during heart-lung bypass. Prior to bypass patients with severe valvular pathology usually maintain satisfactory circulation despite anesthesia and the trauma of thoracotomy; it is only after bypass, when the valvular hemodynamics have been improved, that there is evidence of insufficient cardiac output.
Whatever the etiology of the depressed cardiac function, there are only two methods of trying to improve myocardial contractility:
(1) maintenance of atrial pressures well above the physiologic range by volume loading to increase end-diastolic ventricular fiber length according to the Frank-Starling principle'; and (2) augmentation of ventricular contractility by a pharmacologic agent.
We have previously reported serial metabolic studies in patients following heart-lung bypass for mitral valve surgery, which showed 491 decrease of both coronary blood flow and myocardial oxygen extraction on the first postoperative day.2 Cardiac output was also depressed, the cardiac index averaging 1.64 L/min/m2, suggesting decreased myocardial oxygen requirements. In these same studies isoproterenol invariably improved cardiac output, and there was an associated increase in ventricular work. These drug-induced changes were accompanied by increased myocardial oxygen consumption, which was greater than the increase in external cardiac work. The increased oxygen consumption was due to a marked increase in coronary blood flow, which more than compensated for a small but consistent decrease in the percentage of myocardial oxygen extraction. In response to isoproterenol there was also decreased total myocardial lactate consumption, as well as a decreased percentage of myocardial lactate extraction.
The present study was carried out to compare the effects of isoproterenol with angiotensin. Angiotensin has established peripheral vasoconstrictor effects,3' while its inotropic effects are disputed.5' 6 It has been used in the therapy of shock because of its effectiveness in raising arterial pressure, and in some cases it has raised cardiac output.7' 8 In many respects its systemic hemodynamic effects are the opposite of those of isoproterenol. We believed that administration of both drugs to patients following open-heart surgery would allow a precise comparison of their effects during this period of decreased myocardial performance and might also provide some information regarding the selection of other drugs that might be better suited to the treatment of patients manifesting the low output syndrome.
Methods
Ten patients were studied on the first morning after open-heart surgery. The cardiac diagnoses were rheumatic heart disease in eight, and angina pectoris and atrial septal defect each in one patient. None of the patients were suffering from low output syndrome and none required vasoactive drugs. Surgical procedures included four aortic replacements with ball-valve prostheses, three mitral commissurotomies, one combined mitral and tricuspid valve replacement with low profile disc prostheses, closure of an atrial septal defect, and a myocardial revascularization procedure. Perfusion was at 2.2 L/min/m2 or greater with roller pumps. A rotating disc oxygenator was employed, and the extracorporeal circuit was primed with moderately diluted, converted citrated blood that had been drawn no more than 3 days previously. Moderate hypothermia, 30 to 32 C, was employed during bypass. The patients were maintained on a volume-cycled respirator via an oral endotracheal tube that was left in place at least until the completion of the studies. They received meperidine and promethazine hydrochloride intravenously as necessary, to suppress voluntary competition with the respirator. At surgery polyethylene catheters were placed into the coronary sinus,9 the right and left atria, and a radial artery. The coronary sinus catheter tip was positioned at the left border of the heart and presumably sampled efflux from the left ventricle almost exclusively. Cardiac output was determined in duplicate by dye-dilution technic during the control state and during administration of each drug. Indocyanine green was injected as a bolus into the left atrium, and blood was continuously sampled from the radial artery through a Gilford densitometer, and the concentration curve was inscribed by a Texas Instruments direct writer. The exponential portion of the downslope was determined and cardiac output was then computed in the conventional fashion. The densitometer deflections were calibrated at the end of each study using dye diluted in samples of the patient's blood. Myocardial The major question that can be raised about the experimental methods concerns the extent to which the content of coronary sinus blood can be used to evaluate events occurring in the left ventricle. This has implications both for metabolic studies and measurement of myocardial blood flow. Several assumptions are made, and these will be briefly evaluated:
1. The coronary sinus is assumed to contain almost entirely blood drained from the left ventricle. Rayford and associates1 " have reviewed evidence suggesting that this is the case in the normal experimental animal.
In the human heart, however, the venous blood flow of the posterior wall 3. It is finally assumed that coronary arteriovenous shunting does not occur in the myocardium. The presence of coronary arteriovenous shunts has not been proven, but it is possible that they do occur, and they may be increased in disease states or in response to pharmacologic agents.
Measurement of coronary blood flow in postoperative patients requires a technic which can be readily performed at the bedside and will not place the patient at additional risk. All currently available technics including those using precordial counting as well as those requiring coronary sinus sampling are subject to the problems of spatial variations in coronary blood flow discussed above. The Krasnow modification of the Kety method was chosen because it is relatively simple to perform and because coronary sinus sampling was necessary for the metabolic studies.
Krasnow and associates suggested that 131I iodo-antipyrine saturation curves could be used to calculate coronary blood flow, and Sapirstein and Mellette'6 have shown that the myocardial distribution volumes for antipyrine are identical with tritiated water and that its equilibrium with intracellular water is rapid and is flow-limited, rather than difusionlimited. Data for partition coefficients between blood and fibrotic areas are not available, but antipyrine distribution might become diffusion-limited in severely scarred areas of the myocardium.
A major difference between the nitrous oxide and antipyrine technics is that arterial antipyrine concentration steadily rises during indicator infusion. The slopes of arterial and coronary sinus antipyrine are identical at equilibrium, and theoretic considerations indicate that the arterio-coronary sinus antipyrine Circulation, Volume XLII, September 1970 difference must be constant if isotope is added to the coronary arterial blood at a constant rate and if coronary blood flow is constant. Although we have followed Krasnow's suggestion and sampled during the first 2 min of antipyrine injection, the rapid changes in arterio-coronary sinus isotope difference suggest that equilibrium had not been reached. In subsequent studies from this laboratory isotope sampling has been carried out between 3 and 5 min after the start of isotope injection. Comparison has been made between myocardial blood flow values calculated from sampling during the first 2 min, as was done in this study, and during the interval from 3 to 5 min. The flow rate calculated from the earlier sampling period was 87 ml/100 g/min, while that calculated from the later period was significantly lower (82 ml/100 g/min). This decrease suggests that the regions of lower blood flow had not come into equilibrium during the earlier period. Thus, the coronary blood flow measurements reported in this study are somewhat higher than they would have been if a later sampling period had been used.
Data During Control State
Observations in the control state showed marked reduction in cardiac index and increased systemic vascular resistance in the four patients with aortic valve disease. The differences in the two groups were statistically significant for both cardiac index (P<0.02) and systemic vascular resistance (P < 0.01). These findings parallel our previous experience2 and that of Rastelli and Kirklin'7 in patients studied after mitral valve surgery.
Other studies performed following aortic valvular surgery have also revealed relatively high cardiac index with normal peripheral resistance."8' 19 The explanation for The effects of isoproterenol upon cardiovascular dynamics and myocardial metabolism in normal subjects and in those with heart disease have been reported by Krasnow and associates.26 They concluded that isoproterenol action was mediated by direct chronotropic and inotropic effects as well as by reduction of afterload to contraction. Responses of individuals with ischemic or valvular heart disease were similar to those of the control subjects. Analysis of the data from our postoperative patients ( gree of free fatty acid mobilization rather than an indication of anaerobic metabolism.
